Cargando…
Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis
Systemic lupus erythematosus was diagnosed in a patient at 43 years old. When proteinuria recurred at 57 years old, the first kidney biopsy was performed, and class IV-G (A)+V lupus nephritis was diagnosed. The prednisolone dose was increased to 40 mg/day, and cyclosporine A was introduced. After 1...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125829/ https://www.ncbi.nlm.nih.gov/pubmed/36070938 http://dx.doi.org/10.2169/internalmedicine.0160-22 |
_version_ | 1785030108884500480 |
---|---|
author | Sawamura, Masato Sawa, Naoki Ikuma, Daisuke Oba, Yuki Yamanouchi, Masayuki Sekine, Akinari Mizuno, Hiroki Hasegawa, Eiko Suwabe, Tatsuya Hoshino, Junichi Kono, Kei Kinowaki, Keiichi Ohashi, Kenichi Ubara, Yoshifumi |
author_facet | Sawamura, Masato Sawa, Naoki Ikuma, Daisuke Oba, Yuki Yamanouchi, Masayuki Sekine, Akinari Mizuno, Hiroki Hasegawa, Eiko Suwabe, Tatsuya Hoshino, Junichi Kono, Kei Kinowaki, Keiichi Ohashi, Kenichi Ubara, Yoshifumi |
author_sort | Sawamura, Masato |
collection | PubMed |
description | Systemic lupus erythematosus was diagnosed in a patient at 43 years old. When proteinuria recurred at 57 years old, the first kidney biopsy was performed, and class IV-G (A)+V lupus nephritis was diagnosed. The prednisolone dose was increased to 40 mg/day, and cyclosporine A was introduced. After 1 year, proteinuria had decreased to 0.1 g/day. Prednisolone was discontinued three years later, and cyclosporine A was continued. Thereafter, proteinuria did not reoccur. At 67 years old, a second kidney biopsy showed complete remission of lupus nephritis. Cyclosporine A enabled permanent discontinuation of glucocorticoids in a patient with lupus nephritis. |
format | Online Article Text |
id | pubmed-10125829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-101258292023-04-26 Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis Sawamura, Masato Sawa, Naoki Ikuma, Daisuke Oba, Yuki Yamanouchi, Masayuki Sekine, Akinari Mizuno, Hiroki Hasegawa, Eiko Suwabe, Tatsuya Hoshino, Junichi Kono, Kei Kinowaki, Keiichi Ohashi, Kenichi Ubara, Yoshifumi Intern Med Case Report Systemic lupus erythematosus was diagnosed in a patient at 43 years old. When proteinuria recurred at 57 years old, the first kidney biopsy was performed, and class IV-G (A)+V lupus nephritis was diagnosed. The prednisolone dose was increased to 40 mg/day, and cyclosporine A was introduced. After 1 year, proteinuria had decreased to 0.1 g/day. Prednisolone was discontinued three years later, and cyclosporine A was continued. Thereafter, proteinuria did not reoccur. At 67 years old, a second kidney biopsy showed complete remission of lupus nephritis. Cyclosporine A enabled permanent discontinuation of glucocorticoids in a patient with lupus nephritis. The Japanese Society of Internal Medicine 2022-09-06 2023-04-01 /pmc/articles/PMC10125829/ /pubmed/36070938 http://dx.doi.org/10.2169/internalmedicine.0160-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Sawamura, Masato Sawa, Naoki Ikuma, Daisuke Oba, Yuki Yamanouchi, Masayuki Sekine, Akinari Mizuno, Hiroki Hasegawa, Eiko Suwabe, Tatsuya Hoshino, Junichi Kono, Kei Kinowaki, Keiichi Ohashi, Kenichi Ubara, Yoshifumi Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis |
title | Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis |
title_full | Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis |
title_fullStr | Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis |
title_full_unstemmed | Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis |
title_short | Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis |
title_sort | successful discontinuation of glucocorticoid treatment after administration of a calcineurin inhibitor for nephrotic syndrome in a patient with lupus nephritis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125829/ https://www.ncbi.nlm.nih.gov/pubmed/36070938 http://dx.doi.org/10.2169/internalmedicine.0160-22 |
work_keys_str_mv | AT sawamuramasato successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT sawanaoki successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT ikumadaisuke successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT obayuki successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT yamanouchimasayuki successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT sekineakinari successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT mizunohiroki successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT hasegawaeiko successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT suwabetatsuya successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT hoshinojunichi successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT konokei successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT kinowakikeiichi successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT ohashikenichi successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis AT ubarayoshifumi successfuldiscontinuationofglucocorticoidtreatmentafteradministrationofacalcineurininhibitorfornephroticsyndromeinapatientwithlupusnephritis |